Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexei Shir

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Infectious Diseases|November 18, 2017
S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced ShockAlexei Shir, Shoshana Klein, Idit Sagiv-Barfi, et al.
Cancer Research|May 9, 2013
Therapeutic destruction of insulin receptor substrates for cancer treatmentHadas Reuveni, Efrat Flashner-Abramson, Lilach Steiner, et al.
Bioconjugate Chemistry|August 15, 2014
Optimization of liganded polyethylenimine polyethylene glycol vector for nucleic acid deliverySalim Joubran, Maya Zigler, Neta Pessah, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in miceYael Langut, Alaa Talhami, Samarasimhareddy Mamidi, et al.
Cancer Immunology Research|June 1, 2016
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune MicroenvironmentMaya Zigler, Alexei Shir, Salim Joubran, et al.
Plos One|May 5, 2026
EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFRAnne Pettikiriarachchi, Yelena Ugolev, Richard Birkinshaw, et al.
Molecular Biology of the Cell|December 15, 2015
Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylationKarina Smorodinsky-Atias, Tal Goshen-Lago, Anat Goldberg-Carp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Infectious Diseases|November 18, 2017
S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced ShockAlexei Shir, Shoshana Klein, Idit Sagiv-Barfi, et al.
Cancer Research|May 9, 2013
Therapeutic destruction of insulin receptor substrates for cancer treatmentHadas Reuveni, Efrat Flashner-Abramson, Lilach Steiner, et al.
Bioconjugate Chemistry|August 15, 2014
Optimization of liganded polyethylenimine polyethylene glycol vector for nucleic acid deliverySalim Joubran, Maya Zigler, Neta Pessah, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in miceYael Langut, Alaa Talhami, Samarasimhareddy Mamidi, et al.
Cancer Immunology Research|June 1, 2016
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune MicroenvironmentMaya Zigler, Alexei Shir, Salim Joubran, et al.
Plos One|May 5, 2026
EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFRAnne Pettikiriarachchi, Yelena Ugolev, Richard Birkinshaw, et al.
Molecular Biology of the Cell|December 15, 2015
Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylationKarina Smorodinsky-Atias, Tal Goshen-Lago, Anat Goldberg-Carp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Pageof 2